Laboratory and testing services - omega scan included Q110 option/no cost.

Ended Purchase Order Awarded Last action

Contract number
75N91023P00564
Awardee
Awarding agency
Obligated
$14,700

Award facts

Contract value 100% obligated
$14,700.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541380 Testing Laboratories and Services
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $14,700 firm fixed price purchase order to Human Metabolome Technologies America, Inc. to provide laboratory and testing services, including an Omega Scan option with no additional cost. The place of performance will be in Bethesda, Maryland. The contract period of performance spans from August 1, 2023 through November 30, 2023. No subcontractors or set aside designations were indicated. The services procured appear to support the NIH NCI's biomedical research efforts through specialized analytical testing and metabolomics analysis.

Quick answers

Who was awarded contract 75N91023P00564?

75N91023P00564 was awarded to Human Metabolome Technologies America, Inc. by National Cancer Institute (National Institutes of Health) on August 1, 2023.

How much is contract 75N91023P00564 worth?

The government has obligated $14,700 on 75N91023P00564.

Was contract 75N91023P00564 competed?

The extent of competition for 75N91023P00564 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award